Literature DB >> 22434813

Thomas John MacLagan (1838-1903).

Derek Doyle1.   

Abstract

Mesh：

Substances：

Year:  2012        PMID： 22434813      PMCID： PMC3308649          DOI： 10.1258/jrsm.2012.12k006

Source DB:  PubMed          Journal:  J R Soc Med        ISSN： 0141-0768            Impact factor:   5.344


× No keyword cloud information.
  7 in total

1.  T.J. Maclagan and the treatment of rheumatic fever with salicin.

Authors:  M W SNEAD; J K AIKAWA
Journal:  AMA Arch Intern Med       Date:  1958-05

2.  Medicine in the 19th century: T. Clifford Allbutt; explanatory notes.

Authors:  A M CHESNEY
Journal:  J Med Educ       Date:  1956-07

3.  The Maclagan family: six generations of service.

Authors:  D Doyle
Journal:  J R Coll Physicians Edinb       Date:  2010-06

4.  The Germ-Theory of Disease applied to the Explanation of the Phenomena of Idiopathic Fever.

Authors:  T J Maclagan
Journal:  Br Med J       Date:  1873-10-04

5.  The early clinical history of salicylates in rheumatology and pain.

Authors:  T Hedner; B Everts
Journal:  Clin Rheumatol       Date:  1998       Impact factor: 2.980

6.  Perthshire pioneer of anti-inflammatory agents (Thomas John Maclagan).

Authors:  W K Stewart; L W Fleming
Journal:  Scott Med J       Date:  1987-10       Impact factor: 0.729

Review 7.  From plant extract to molecular panacea: a commentary on Stone (1763) 'An account of the success of the bark of the willow in the cure of the agues'.

Authors:  John N Wood
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2015-04-19       Impact factor: 6.237
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.